NWM
ABBV icon

NEIRG Wealth Management’s AbbVie ABBV Stock Holding History

NEIRG Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,513
Closed -$608K – 2
2023
Q2 		$608K Sell
4,513
-56,178
-93% -$8.24M 0.11% 91
2023
Q1 		$9.67M Sell
60,691
-2,071
-3% -$317K 1.68% 20
2022
Q4 		$10.1M Sell
62,762
-25
-0% -$3.83K 1.91% 15
2022
Q3 		$8.43M Sell
62,787
-618
-1% -$88.7K 1.69% 16
2022
Q2 		$9.71M Buy
63,405
+5,327
+9% +$814K 2.12% 12
2022
Q1 		$9.41M Buy
58,078
+1,005
+2% +$146K 1.84% 19
2021
Q4 		$7.73M Buy
+57,073
New +$6.74M 1.48% 26

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NEIRG Wealth Management's ABBV Position: Q3 2023 in Review

NEIRG Wealth Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 4,513 shares — an estimated $608K sold.

NEIRG Wealth Management first reported a position in ABBV in Q4 2021 and held it in 7 quarters. The position peaked at $10.1M in Q4 2022. 3,112 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • NEIRG Wealth Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • NEIRG Wealth Management sold 4,513 AbbVie shares in Q3 2023, an estimated $608K.
  • NEIRG Wealth Management first reported a position in AbbVie in Q4 2021 and held it in 7 quarters.
  • NEIRG Wealth Management's AbbVie position peaked at $10.1M in Q4 2022.
  • 3,112 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on NEIRG Wealth Management's 13F filing for Q3 2023.